Yes, rats can get high. They have the same basic brain chemistry that allows psychoactive substances to produce intoxicating effects in humans, including a fully functional endocannabinoid system with receptors throughout their brains and spinal cords. This is exactly why rats are the most commonly used animals in drug research: their neurological response to substances like THC, cocaine, and opioids closely mirrors our own.
Why Rats Respond to the Same Drugs We Do
Rats possess CB1 receptors, the primary targets of THC, distributed across their central nervous system. These receptors are concentrated in brain regions involved in memory, movement, and pain processing, and are found in both male and female rats in patterns that closely resemble those in human tissue. CB1 receptors sit on the ends of nerve cells and regulate the release of chemical signals, which is how THC disrupts normal brain communication in both species.
Beyond cannabinoid receptors, rats share the mesolimbic dopamine system that underlies the “high” from virtually every recreational drug. This reward pathway runs from the midbrain to a structure called the nucleus accumbens, and every drug with addiction potential increases dopamine release along this circuit, either directly or indirectly. THC does this by activating CB1 receptors that influence the release of other signaling chemicals, which in turn ramp up dopamine activity. The subjective result in rats, as best as researchers can measure it, is a rewarding experience that motivates them to seek the drug again.
What “High” Looks Like in a Rat
Rats obviously can’t describe their experience, so researchers rely on a well-established set of four behavioral markers collectively known as the “cannabinoid tetrad.” When a rat is under the influence of THC or synthetic cannabinoids, it displays:
- Reduced movement: The rat becomes noticeably less active and explores its environment less.
- Catalepsy: The rat holds unusual, frozen postures for extended periods, something it would never do sober.
- Lower body temperature: Core temperature drops measurably after THC exposure.
- Reduced pain sensitivity: The rat shows delayed reactions to mildly painful stimuli.
These four signs appear reliably and predictably after THC administration, and they can be blocked by giving the rat a drug that blocks CB1 receptors, confirming the effects are specifically cannabinoid-driven rather than general sedation.
Memory and Cognitive Effects
THC impairs rat cognition in ways that parallel the forgetfulness and mental fog humans report when high. In radial arm maze tasks, where rats must remember which arms they’ve already visited to find food, THC causes significant working memory errors. Rats forget where they’ve already been and revisit the same locations repeatedly.
Research from a study published in Neuropsychopharmacology pinpointed where this happens: blocking CB1 receptors specifically in the hippocampus, the brain’s memory center, completely prevented THC-induced memory impairment. But here’s the interesting part: that same hippocampal blockade did nothing to prevent the other effects of THC like reduced movement, catalepsy, or lowered body temperature. This tells us the memory disruption is a distinct effect mediated by a specific brain region, not just a side effect of being sedated.
How Long the Effects Last
After inhaling cannabis smoke under controlled conditions, rats reach peak THC blood levels within about 10 minutes. From there, THC declines with a half-life of roughly 3.7 hours, meaning it takes about that long for blood concentrations to drop by half. Because THC is fat-soluble, it gets absorbed into fatty tissue and then slowly released back into the bloodstream, which extends the timeline. Behavioral effects in rats typically track with these blood levels, with the most pronounced signs fading over several hours but subtle effects lingering longer as stored THC continues to trickle out.
Rats and Drug Preferences
Rats don’t just passively respond to drugs. They actively seek them out. In self-administration studies, rats will press levers hundreds of times to receive doses of cocaine, heroin, alcohol, and other substances. Their individual responses vary in ways that mirror human vulnerability to addiction. When chronically exposed to cocaine, only about 15 to 20 percent of rats will compulsively choose it over other rewards like food or social interaction. With heroin, that number climbs to around 50 percent under similar conditions.
THC self-administration in rats has historically been harder to demonstrate than with stimulants or opioids, which tracks with the lower addiction potential of cannabis compared to those drugs. But rats do show conditioned place preference for environments where they’ve received THC, meaning they associate those locations with a rewarding experience and choose to spend more time there.
It Takes a Lot of THC to Harm a Rat
The lethal dose of THC in rats is extraordinarily high relative to the amount that produces intoxication. Oral THC kills 50 percent of rats (the standard toxicity benchmark) at doses between 800 and 1,270 milligrams per kilogram of body weight, depending on the formulation. Through intravenous injection, the lethal dose drops to 36 to 40 milligrams per kilogram. To put this in perspective, the doses used to produce behavioral effects in research are typically in the range of 1 to 10 milligrams per kilogram, meaning a rat would need to consume roughly 100 to 1,000 times a psychoactive dose before reaching life-threatening toxicity. This enormous safety margin is one reason cannabis has such a low overdose risk across species.
Beyond THC
Rats respond to essentially every class of psychoactive drug that affects humans. They show stimulant effects from amphetamines, sedation from benzodiazepines, hallucination-like behavioral changes from psychedelics, and euphoria-related behaviors from opioids. In each case, the same neurotransmitter systems are involved. The shared biology is so reliable that nearly every psychiatric and addiction medication on the market was first tested in rats, with behavioral responses in the animals predicting human effects with reasonable accuracy.
The similarities have limits, of course. Rats metabolize many drugs faster than humans, their subjective experience remains fundamentally unknowable, and they can’t make the kind of complex decisions about drug use that define human addiction. But on the basic question of whether the same chemical changes happen in their brains, producing rewarding, perception-altering, and cognition-impairing effects, the answer is clear.